Although mutations of the MET gene are not common in GC,4 MET protein overexpression rates in 50% of advanced gastric cancers5 and accordingly, MET gene amplification rates vary from 4%‐10% of gastric tumour patients.6, 7. The gene discussed is MET; the disease is gastric cancer.